Uh-Oh Labs

Our company began in 2018 with the goal of giving everyone access to powerful, personalized, and private diagnostics and healthcare services. We began developing molecular diagnostic technology to enable lab-quality tests without the expensive laboratory, initially targeting STDs but with the capability of detecting many other infectious diseases.

With the worldwide outbreak of COVID-19, our small team quickly pivoted in 2020 to using our same core technology to develop a diagnostic test for SARS-CoV-2 in order to address the urgent need for testing. We were accepted to the NIH RADx program to help accelerate our efforts and have since completed clinical studies for point-of-care use for our COVID-19 diagnostic test. We are now seeking EUA approval and looking to grow our team to support both our initial launch and continued development of a low-cost, integrated testing platform for both point of care and home use.